To meaningfully improve the health of Americans, new policies must target all of the drivers of health, including education, economic stability, neighborhoods and environments, social and community well-being, and historic inequities.
Reducing prescription drug prices does not have to come at the price of pharmaceutical innovation.
New poverty, income, and health insurance data confirm that poverty is a policy choice.
Value-based pricing aligns prescription drug prices to their clinical benefits, leading to lower spending and better health outcomes.
The Medicaid coverage gap, which leaves more than 2 million people uninsured, must be closed with a comprehensive, permanent solution.
New data and analysis reveal important health disparities and barriers to care for transgender adults and what can be done to address these issues.
With intention, humility, and supportive policies, nonprofit hospitals can be key players in improving community health.
Three case studies illustrate how humility, collaboration, and community-driven processes are essential to impactful work.
The federal government and policymakers must address health disparities and barriers to care for transgender communities by implementing holistic policy solutions.
Key legislative proposals, including drug price negotiation and inflation caps, would save consumers and businesses millions of dollars.
The American Rescue Plan gives states additional flexibility to expand health coverage.
Vaccinations can help the U.S. workforce and economy recover from the COVID-19 pandemic.
Bulk purchasing of prescription drugs would allow federal and state governments to better respond to epidemics—including opioid addiction and HIV/AIDS—and pandemics such as COVID-19.
Until the United States achieves a higher rate of immunity, the coronavirus remains a threat to public health and the nation’s economic recovery.
Heath reforms to expand coverage and lower costs can be designed to also address health inequities and disparities.
